Startups
Edit
InVirtuoLabs: Revolutionizing Drug Discovery with AI and Simulations
https://www.invirtuolabs.com/Last activity: 29.10.2026
Active
Discover InVirtuoLabs, a pioneering biotech startup in Switzerland, leveraging advanced machine learning and physics-based simulations to transform drug discovery. Explore our innovative solutions, strategic partnerships, and commitment to faster, cost-effective drug development.
Overview
Location
Switzerland
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 27, 2026 | InVirtuoLabs closes R&D agreement with Helsinn | Under the terms of the agreement, Helsinn will provide InVirtuoLabs with access to a proprietary library of structurally diverse compounds, including validated hits with confirmed biological activity against an undisclosed therapeutic targ... |
| Feb 12, 2026 | InVirtuoLabs to lead €2.3M Eurostars grant project NEUROSPARK | Virtual Cell Models act as AI-driven “digital twins” of living cells, simulating how diseased cells respond to potential therapies. In practice, the approach helps research teams prioritize the most promising molecules, reduce trial-and-er... |
| Oct 31, 2025 | More than 20 Swiss biotech companies to exhibit at Bio Europe | Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi... |
| Jul 28, 2025 | InVirtuoLabs unveils AI-powered platform to accelerate drug discovery | InVirtuoLabs, a startup incubated at USI Startup Centre in Lugano, has officially launched its InVirtuo Platform: an end-to-end, AI-powered system designed to enhance the early stages of drug discovery. The launch follows the completion of... |
| Feb 21, 2025 | InVirtuoLabs secures €2.85 million to accelerate drug discovery | |
| Feb 20, 2025 | €2.85 million to accelerate AI in drug discovery | At the heart of InVirtuoLabs' innovation is the Next Generation Virtual Lab, a proprietary platform that uses AI and molecular modeling to identify and optimize drugs with proven precision. This approach allows for doubling success ra... |
| Dec 5, 2024 | Expediting drug discovery with AI: In Virtuo Labs wins Boldbrain Startup Challenge | The 2024 Boldbrain Startup Challenge is the acceleration program for innovative ideas organized by Fondazione Agire in collaboration with USI Startup Centre and supported by the Department of Finance and Economy (DFE) and BancaStato. The p... |
| Nov 26, 2024 | The finalists of the Boldbrain Startup Challenge have been selected | The seventh edition of the Boldbrain Startup Challenge is entering its final phase. The acceleration program, which began on August 29, offered the selected innovative projects the opportunity to develop and refine their initial ideas thro... |
| InVirtuoLabs | “Discover InVirtuoLabs, a pioneering biotech startup in Switzerland, leveraging advanced machine learning and physics-based simulations to transform drug discovery. Explore our innovative solutions, strategic partnerships, and commitment to... |
Reviews 0
FAQ about InVirtuoLabs: Revolutionizing Drug Discovery with AI and Simulations
What has the press written about InVirtuoLabs: Revolutionizing Drug Discovery with AI and Simulations?
Parsers VC has collected 10 articles mentioning InVirtuoLabs: Revolutionizing Drug Discovery with AI and Simulations, among them “InVirtuoLabs closes R&D agreement with Helsinn” (Feb 27, 2026) and “InVirtuoLabs to lead €2.3M Eurostars grant project NEUROSPARK” (Feb 12, 2026).
Is InVirtuoLabs: Revolutionizing Drug Discovery with AI and Simulations still active?
Yes, InVirtuoLabs: Revolutionizing Drug Discovery with AI and Simulations is active; its latest activity on Parsers VC dates from Oct 29, 2026.